Synthetic Lethalityin Pancreatic Cancer: Discoveryof a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits HomologousRecombination and Synergizes with Olaparib. This evidence concerns the gene BRCA2 and pancreatic neoplasm.